DIAGNOSTIC TEST KITS COMPRISING

Brand Owner (click to sort) Address Description
GENESWELL BCT GENCURIX Inc. 4F, Hanwha Bizmetro 1cha Digital-ro 242, Guro- gu, Seoul 08394 Republic of Korea Diagnostic test kits comprising of medical diagnostic reagents for use in breast cancer detection; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Medical diagnostic reagents;Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical apparatus and instruments for use in detection of cancer and breast cancer; Medical diagnostic apparatus for testing DNA;BCT;
SNAP TBDX IDEXX LABORATORIES, INC. One IDEXX Drive Westbrook ME 04092 Diagnostic test kits comprising of a lateral flow assay device and immunological reagents, for determining the presence, absence and/or quantity of antigen or antibodies associated with pathogens transmitted by ticks for veterinary use;
SYNCHROGAIT Capilet Genetics AB Uppsala Science Park SE-751 83 UPPSALA Sweden [ Diagnostic test kits comprising diagnostic preparations and test equipment all for use in measuring or predicting gait and coordination in animals for veterinary purposes ];SYNCHRO GAIT;Veterinary services;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A new gene-MN-and proteins/polypeptides encoded therefrom are disclosed. Recombinant nucleic acid molecules for expressing MN proteins/polypeptides and recombinant proteins are provided. Expression of the MN gene is disclosed as being associated with tumorigenicity, and the invention concerns methods and compositions for detecting and/or quantitating MN antigen and/or MN-specific antibodies in vertebrate samples that are diagnostic/prognostic for neoplastic and pre-neoplastic disease. Test kits embodying the immunoassays of this invention are provided. MN-specific antibodies are disclosed that can be used diagnostically/prognostically, therapeutically, for imaging, and/or for affinity purification of MN proteins/polypeptides. Also provided are nucleic acid probes for the MN gene as well as test kits comprising said probes. The invention also concerns vaccines comprising MN proteins/polypeptides which are effective to immunize a vertebrate against neoplastic diseases associated with the expression of MN proteins. The invention still further concerns antisense nucleic acid sequences that can be used to inhibit MN gene expression, and polymerase chain reaction (PCR) assays to detect genetic rearrangements.